pyruvate kinase deficiency
Jump to navigation
Jump to search
Pathology
- deficiency of enzyme pyruvate kinase in erythrocytes
- hemolytic anemia
Genetics
Clinical manifestations
Laboratory
- serum bilirubin
- complete blood count (CBC)
- pyruvate kinase genotyping
- serum haptoglobin
- osmotic fragility
- pyruvate kinase in erythrocytes
- stool urobilinogen
- see ARUP consult[3]
Complications
Management
- blood transfusions as needed
- exchange transfusion may be needed in newborns with jaundice
- splenectomy may reduce hemolysis
- mitapivat (Pyrukynd) is a pyruvate kinase activator FDA-approved to treat hemolytic anemia in adults with pyruvate kinase deficiency
More general terms
Additional terms
References
- ↑ PubMed Health: Pyruvate kinase deficiency http://www.ncbi.nlm.nih.gov/pubmedhealth/PMH0002177/
- ↑ Frye RE eMedicine (Medscape): Pyruvate Kinase Deficiency http://emedicine.medscape.com/article/125096-overview
- ↑ 3.0 3.1 ARUP consult: Pyruvate Kinase Deficiency (PKLR) Sequencing https://arupconsult.com/ati/pyruvate-kinase-deficiency-pklr-sequencing